Kevin M. Hart

Kevin M. Hart has no picture

Kevin M. Hart has over twenty years of experience as a trial lawyer. Mr. Hart has litigated civil and criminal cases in both federal and state courts representing businesses and individuals in matters ranging from the sale and break-up of corporations, securities fraud, franchise disputes, shareholder disagreements, criminal fraud and embezzlements. He has also represented both the FDIC and RTC in various types of litigation.Mr. Hart has a significant amount of experience defending companies and individuals. He has an in-depth understanding of the prosecution function based on his experience as a prosecutor.From 1978 to 1980, Mr. Hart was Deputy Attorney General with the State of New Jersey, focusing on white-collar criminal matters. In 1986, he was certified by the Supreme Court of New Jersey as a Certified Civil Trial Attorney and was re-certified in 1994 and 2002.Mr. Hart has been an adjunct professor of Business Environment and Policy at Rider University since 1983. He has lectured frequently on topics related to business and litigation issues including fraud, white collar crime, shareholder disputes and acquisitions and mergers. Mr. Hart serves as a legal analyst in these areas for Fox News, NBC News and Comcast CN8.


Articles By This Author

YAZ®, Yasmin® and Ocella® - Case Management Order

no picture

As we have discussed in previous posts, studies have shown that the ingredients contained in YAZ®, Yasmin® and Ocella® have been linked to various forms of severe side-effects. Reportedly, these side-effects include: heart attack, stroke, deep vein thrombosis (also known as DVT or blood clots), internal organ damage (including gallbladder damage), myocardial infarction and pulmonary embolism. Recently, a large number of YAZ® lawsuits have been designated as Mass Tort or Multidistrict Litigation (MDL) cases.

After receiving Mass Tort designation on February 9, 2010, in the New Jersey Superior Court, Bergen County, Judge Martinotti issued an Initial Order for Case Management on February 18, 2010. The Case Management Order (CMO) is the basis for how pending and future cases are managed leading up to trial. A few of the issues outlined in the CMO are:

  1. the method for handling discovery requests;
  2. preservation of records;
  3. cases to be filed in the future;
  4. methods for filing pleading documents; and
  5. methods for filing motions.

An initial Case Management Conference (CMC) has been scheduled for April 26, 2010. At that time counsel for all of the parties will appear before Judge Martinotti to discuss suggested procedures that will facilitate a just, expeditious and inexpensive resolution to the litigation. Counsel for the parties will meet and confer before the CMC to seek consensus with regard to the items that are to be discussed during the conference.

New Jersey State Supreme Court Grants Mass Tort Designation to YAZ®, Yasmin® and Ocella® Cases

no picture

As we have discussed in previous posts, studies have shown that the ingredients contained in the birth control products YAZ®, Yasmin® and Ocella® have been linked to various forms of severe side-effects. Reportedly, these side-effects include: heart attack, stroke, deep vein thrombosis (also known as DVT or blood clots), internal organ damage (including gallbladder damage), myocardial infarction and pulmonary embolism.
 

On February 9, 2010, the New Jersey State Supreme Court granted Mass Tort designation to YAZ®, Yasmin® and Ocella® cases, pursuant to the application made under Rule 4:38A. Accordingly, all pending and future New Jersey state court actions arising out of the use of the oral contraceptives YAZ®, Yasmin® and Ocella® are designated as a mass tort for centralized case management purposes. Any and all such complaints that have been filed in the various counties and that are under or are awaiting case management and/or discovery shall be transferred from the county of venue to Superior Court, Law Division, Bergen County, and assigned to Judge Brian R. Martinotti, J.S.C.
 

If you, or someone you know, has been injured as a result of taking these medications, contact Stark & Stark’s Mass Tort/Pharmaceutical Litigation Team. At Stark & Stark we pursue claims throughout the nation against drug manufacturers, so they can be held accountable when the drugs they market are proven to be defective or cause catastrophic injury to the people who use them. Contact Stark & Stark to speak with one of the Mass Tort/ Pharmaceutical Litigation attorneys, free of charge, who can help assess any claims that you might have against the YAZ®, Yasmin® or Ocella® manufacturers.

YAZ®, Yasmin® and Ocella® Cases Transfered to MDL in the United States Distric Court

no picture

Since the beginning of October 2009, over 350 YAZ®, Yasmin® and Ocella® cases from various jurisdictions throughout the country have been transferred to the MDL in the United States District Court for the Southern District of Illinois. On November 9, 2009, motions were filed to appoint Plaintiffs’ lead counsel and a Plaintiffs’ Steering Committee. The Court will hold a conference in the coming weeks to address the newly transferred cases and pending motions.

Stark & Stark’s Mass Tort/Pharmaceutical Litigation Team pursues claims throughout the nation against drug manufacturers, so they can be held accountable when the drugs they market are proven to be defective or cause catastrophic injury to the people who use them. If you feel you have experienced any side-effects from taking YAZ® or Yasmin® (or the generic brand, Ocella®), you can contact Stark & Stark and speak to one of the Mass Tort/ Pharmaceutical Litigation attorneys, free of charge, who can help assess any claims that you might have against the YAZ®, Yasmin® or Ocella® manufacturers.

Defendants in NuvaRing® Litigation Files Motion For Entry of Lone Pine Case Management Order

no picture

NuvaRing®, the combined contraceptive vaginal ring that is supposed to provide month-long birth control, is currently involved in a Multi-District Litigation (“MDL”) in the United States District Court for the Eastern District of Missouri.  Plaintiffs have advanced claims that NuvaRing® is responsible for injuries in some individuals.
 

In recent months, the defendants filed a motion for the entry of a Lone Pine case management order. Such an order would have required all existing and future plaintiffs in the NuvaRing® MDL to submit a Rule 26(a)(2), or case specific, expert report attesting to a reasonable degree of medical certainty that NuvaRing® caused the injury suffered by each plaintiff. The defendants claimed that the entry of a Lone Pine case management order would promote judicial efficiency by discouraging claims that did not have merit and allowing the Court to group cases with legal similarities. However, the plaintiffs argued that the entry of a Lone Pine case management order would actually have amounted to an onerous burden that would have the effect of discouraging many plaintiffs from filing otherwise viable claims against the defendants. Accordingly, the Court ruled in favor of the plaintiffs and denied the defendants' motion for entry of a Lone Pine case management order, without prejudice.

NuvaRing® Plaintiffs File Master Consolidated Complaint

no picture

NuvaRing®, the once-a-month combined contraceptive vaginal ring which is supposed to  provide month-long birth control, is currently involved in a Multi-District Litigation (“MDL”) in the United States District Court for the Eastern District of Missouri based on claims that NuvaRing® is responsible for injuries in some individuals. 

On February 6, 2009, Plaintiffs filed a Master Consolidated Complaint (“Master Complaint”), which will serve to supplement the complaints in the individual cases.  The cases were originally filed in different state courts and transferred to the MDL.  The Master Complaint will make entry of cases into the MDL from around the country more efficient by allowing the incoming plaintiffs to simply refer to the Master Complaint.  This Master Complaint makes the necessary jurisdictional claims, as well as alleging a variety of counts for Negligence, Fraud, and other causes of action.

Update on NuvaRing® Litigation Status

no picture

NuvaRing® is marketed as a once-a-month, combined contraceptive vaginal ring that provides month-long birth control.   It is sold in the United States by Organon USA Inc., a New Jersey corporation with its principal place of business in Roseland, New Jersey, and Organon International, Inc., headquartered in the Netherlands. Its parent company, Schering-Plough Corp., is located in Kenilworth, New Jersey.  Complaints have alleged that hormone levels in NuvaRing® have resulted in death, the breakdown of tissue and organs, amputation, heart attacks, ischemic strokes, and deep vein thrombosis. 

 

Courts in the United States have consolidated NuvaRing® claims in two locations:  1) New Jersey Superior Court, Law Division, Civil Part, Bergen County Vicinage; and 2) the United States District Court for the Eastern District of Missouri.  As of July 1, 2009, there have been 79 cases filed in new Jersey Superior Court and more than one hundred in the Eastern District of Missouri.
 

FDA Issues Hydroxycut® Warning, Makers Issue Voluntary Recall

no picture

Hydroxycut®, the group of dietary supplements which claim to be fitness and weight loss aids, have recently been linked to severe, and sometimes life threatening injuries. Recent reports state that these injuries include damage to the liver, kidneys and other internal organs, rhabdomyolysis (severe muscle damage), cardiovascular disorders and even death. On May 1, 2009, the United States Food and Drug Administration (FDA) issued a warning urging consumers to discontinue the use of the supplements due to the severe health dangers associated with Hydroxycut®. Following the warning from the FDA, the makers of Hydroxycut® issued a voluntary recall of the supplements.

These supplements include Hydroxycut® Regular Rapid Release Caplets, Hydroxycut® Caffeine-Free Rapid Release Caplets, Hydroxycut® Hardcore Liquid Capsules, Hydroxycut® Max Liquid Capsules, Hydroxycut® Regular Drink Packets, Hydroxycut® Caffeine-Free Drink Packets, Hydroxycut® Hardcore Drink Packets (Ignition Stix), Hydroxycut® Max Drink Packets, Hydroxycut® Liquid Shots, Hydroxycut® Hardcore RTDs (Ready-to-Drink), Hydroxycut® Max Aqua Shed, Hydroxycut® 24, Hydroxycut® Carb Control and Hydroxycut® Natural. Hydroxycut® supplements are manufactured and distributed by Iovate Health Sciences and MuscleTech Research and Development, Inc.

New Jersey's Investigation of Student Loan Industry's Dealings With Colleges and Universities

no picture

As the student loan scandal widens, it seems that most colleges and universities will have to examine and modify any existing internal policies that outline appropriate conduct between employees and outside service providers.

In both New Jersey and New York, news is unfolding of possible inappropriate practices of college and university employees accepting perks ranging from stock options, the use of vacation homes, trips, as well as cash provided by loan industry representatives in an effort to become one of the institution’s preferred lenders for prospective students.

More than 90% of all students have some form of student loan, and more than 80% utilize the private lenders recommended by the university. Since these loans are for the most part subsidized by the government, there is little risk of non-payment to the lenders, in fact student loans are not even dischargable in bankruptcy.

Colleges and universities must now face the reality that in spite of their enlightened existence, they too are subject to conflicts of interest, as well as possible civil and even criminal liability.

 

Counsel's Selection and Compilation of Discoverable Documents Should Be Protected Under the Work Product Doctrine

no picture

Large-scale, industrial construction litigation naturally involves high volumes of documents exchanged through discovery, which must be marshaled, reviewed and compiled in some form by counsel. Many times, adverse parties seek access to such compilations of what are otherwise completely discoverable documents. The Federal Courts have protected compilations under what has been termed the "selection and compilation" theory of the work product doctrine. Federal Courts have held that, in cases that involve reams of documents and extensive document discovery, the selection and compilation of documents is often more crucial than legal research. James Julian, Inc. v. Raytheon Co., 93 F.R.D. 138, 144 (D.Del.1982). The most widely cited cases regarding the doctrine are the Third Circuit's decision in Sporck v. Peil, 759 F.2d 312 (3d Cir.1985), cert. denied, 474 U.S. 903 (1985), and the Eighth Circuit's decision in Shelton v. American Motors Corp., 805 F.2d 1323 (8th Cir.1986). In Sporck, defendants produced thousands of documents and defendant's counsel selected and had defendant review certain documents in anticipation of his deposition. Defendant’s counsel did not claim any of the documents were work product; however, the court upheld counsel's objections to deposition questions which sought the identification of documents the deponent reviewed to prepare for the deposition. The court held that counsel's selection and compilation of the documents fell within the category of highly protected opinion work product, because the compilation of the documents would reveal counsel's mental impressions and opinions as to how the documents related to the issues. It further held that an attorney's legal strategy, his intended lines of proof, his evaluation of the strengths and weaknesses of his case and the inferences he draws from the facts are all opinion work product. The court stated:

Such material is accorded an almost absolute protection from discovery because any slight factual content that such items may have is generally outweighed by the adversary system's interest in maintaining the privacy of an attorney's thought processes and in ensuring that each side relies on its own wit in preparing their respective cases.

Id. at 316.

In Shelton, defendant's in-house counsel refused to respond to deposition questions seeking information regarding the existence or non-existence of documents in defendant's possession. Counsel argued that: 1) relevant documents were already produced, interrogatories were answered, counsel’s knowledge was acquired solely in her efforts to assist her client in litigation and thus constituted work product; and 2) any recollection of particular documents on certain subjects would reveal those to which counsel attached particular significance, revealing her theories and opinions. The court held that counsel had no first hand factual information related to the claims and that the questions she was asked sought more than just information about the existence of documents. The court agreed that the selective review and recollection of documents reflects the attorney's professional judgment on the issues, as well as her legal theories and thought processes. It found that "[i]n cases that involve reams of documents and extensive document discovery, the selection and compilation of documents is often more crucial than legal research...." Id. at 1328; see also, In re Grand Jury Subpoenas Dated October 22, 1991 and November 1, 1991, 959 F.2d 1158 (2d Cir.1992) (applying the Sporck principle that production of otherwise unprivileged documents that could be protected from discovery if their disclosure presented a real concern that the thought processes of counsel would be exposed); Santiago v. Miles, 121 F.R.D. 636, 638-40 (W.D.N.Y.1988) (court applied Sporck, finding that Second Circuit has recognized the selection and compilation doctrine; while data in computer printouts consists of unprivileged facts, printouts were prepared at direction of counsel and reflect counsel's selection process and mental impressions, deserving of protection in absence of strong showing of necessity and unavailability).

Thus counsel’s selection and compilation of otherwise discoverable documents should be protected under the work product doctrine.

Technorati Tags: :

Sub-subcontractor's Claim Against an EPC Contractor Based Upon Unjust Enrichment or Quantum Meruit Theories

no picture

It is well established that sub-subcontractors may not maintain direct actions against EPC contractors or owners based upon a theory of unjust enrichment or quantum meruit. The Appellate Division in Insulation Contracting, Inc. v. Kravco, 209 N.J. Super. 367 (App. Div. 1986), held that, in such situations, a basic premise of the theories of unjust enrichment and quantum meruit is that there must be a clear expectation by the defendant that it will be responsible for payment directly to the plaintiff. The fact that the defendant may have received a benefit for which it has not paid is not sufficient. Id. at 378.

Such was also the explicit holding in F. Bender, Inc. v. Muscarelle, Inc., 304 N.J. Super. 282, 285 (App. Div. 1997):

We know of no case where the statutory protections given to a subcontractor or sub-subcontractor by filing a notice of intention or stop notice could be replicated by a common law claim based upon quantum meruit. Such a rule would create havoc in the construction industry. See Insulation Contracting & Supply v. Kravco, Inc., supra, (denying similar reimbursement in a claim by a sub-subcontractor against the prime contractor after the subcontractor for whom the plaintiff had performed defaulted).

 In this case, Hertz had an obligation to pay its contractor, and, Muscarelle, the contractor, had an obligation to pay its subcontractor, Tri-Gee, who in turn had an obligation to pay plaintiff, its subcontractor. When plaintiff performed, it had a claim only against Tri-Gee unless it filed a notice of intention or stop notice in compliance with the Mechanics' Lien Law. It is true that Hertz and/or Muscarelle may have received the benefit of plaintiff's work; however, Tri-Gee owes plaintiff for that work.

Quantum meruit, which plaintiff seeks, requires that there be unjust enrichment. Callano v. Oakwood Park Homes Corp., 91 N.J. Super. 105, 108- 109, 219 A.2d 332 (App.Div.1966). Here, there was no unjust enrichment.

Id. at 284-5.

Therefore, the sub-subcontractor’s unjust enrichment and quantum meruit claims against the EPC contractor and owner will not support any cognizable claim for relief, and must be dismissed. Printing Mart-Morristown v. Sharp Electronics Corp., 116 N.J. 739, 746 (1989); Leon v. Rite Aid Corp., 340 N.J. Super. 462, 466 (App. Div. 2001); Rule 4:6-2(e). The sub-subcontractor is thus left to seek redress under the statutory provisions of the construction lien law, and through its direct contractual claims against the subcontractor.

Technorati Tags: :